On August 15, 2018, New Water Capital L.P. (New Water), a Boca Raton-based private equity firm focused on lower-middle market companies, completed its acquisition of Trillium Health Care Products (THC), a premier contract manufacturer of category-leading OTC products for some of the world’s top pharmaceutical companies.
New Water was represented in Canada by Mario Nigro, Jennifer Honeyman, Jared Bachynski and Terry Grazier (corporate), Frank Mathieu, Jean-Guillaume Shooner and Adam Drori (tax), Mark McElheran and Chad Bass-Meldrum (banking and finance), Natasha VandenHoven, Allyson Marta and Kelly O’Ferrall (employment, labour and pensions), Michael Laskey and Gideon Kwinter (competition/anti-trust), Larry Cobb (environmental), Ryan Sheahan and Jessica Rutledge (regulatory), and Dana Porter and Ciaron Czajkowski (real estate) of Stikeman Elliott LLP and in the US by Douglas Gessner, Corey Fox, Cole Parker and Eric Sweigard of Kirkland & Ellis LLP.
The majority shareholders of THC were represented by Matthew Hibbert, Andrew Bourns and Todd Melchior (corporate), Mark Jadd (tax) and Michael Henriques (banking and finance) of Dentons Canada LLP.
